Bajaj Auto | The company announced a share buyback worth ₹4,000 crore. The board has approved the proposal for buyback of up to 4,000,000 shares of face value of ₹10 each at a price of ₹10,000 per share for a total consideration not exceeding ₹4,000 crore, the Pune-based firm said in a regulatory filing.
Adani Enterprises | The company said its step-down subsidiary, Mumbai International Airport Ltd (MIAL), has won the arbitration case against the Airports Authority of India (AAI). The dispute revolved around certain reliefs sought by MIAL due to the impact of the force majeure event, namely the COVID-19 pandemic, as per the Operation, Management, and Development Agreement (OMDA) dated April 4, 2006.
Brigade Enterprises | The realty firm said it has inked memorandums of understanding (MoUs) with the Tamil Nadu government, pledging an investment of over ₹3,400 crore. The agreements were formalised during the Tamil Nadu Global Investors Meet (GIM) 2024, in the presence of Tamil Nadu Chief Minister M.K. Stalin, Brigade Enterprises said in a regulatory filing.
SG Mart | The company's board of directors has given its nod to some corporate actions, including the issuance of bonus shares and a stock split. The approved bonus share issuance entails a 1:1 ratio, translating to one bonus equity share for every existing equity share held by eligible shareholders as of the yet-to-be-announced record date.
Caplin Point Laboratories | The drug firm said it has signed a Memorandum of Understanding with the state government during the Tamil Nadu Global Investors Meet, 2024. Under the MoU, the Caplin group of companies, which includes Caplin Point Laboratories along with its subsidiaries Caplin Steriles and Caplin One Labs, has pledged an investment of ₹700 crore over the next five years.
Aurobindo Pharma | The drug firm said it has received a positive outcome from the US Food and Drug Administration following an inspection of its Unit VI-B, a formulation manufacturing facility located in Telangana’s Chitkul village, in Sangareddy district. The FDA conducted the inspection from September 22-29, 2023.
Bajaj Finserv | Financial services firm said its insurance arm Bajaj Allianz General Insurance Company Ltd and Bajaj Allianz Life Insurance Company Ltd have reported their third quarter premiums. The gross direct premium underwritten by Bajaj Allianz General Insurance for December reached ₹1,425.10 crore, an impressive 18% increase year-on-year.
Cipla | The drug major said its wholly-owned subsidiary Cipla (EU) Ltd entered into a strategic collaboration with Kemwell Biopharma Private Ltd (via its subsidiary Kemwell Biopharma UK Ltd) and Manipal Education & Medical Group (via its subsidiary MNI Ventures, Mauritius).